Gossamer Bio
GOSS
GOSS
129 hedge funds and large institutions have $533M invested in Gossamer Bio in 2022 Q2 according to their latest regulatory filings, with 18 funds opening new positions, 35 increasing their positions, 51 reducing their positions, and 26 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
more ownership
Funds ownership: →
more capital invested
Capital invested by funds: $ → $
9% less funds holding
Funds holding: 141 → 129 (-12)
31% less first-time investments, than exits
New positions opened: 18 | Existing positions closed: 26
31% less repeat investments, than reductions
Existing positions increased: 35 | Existing positions reduced: 51
Holders
129
Holding in Top 10
4
Calls
$10.7M
Puts
$1.23M
Top Buyers
| 1 | +$10.9M | |
| 2 | +$8.82M | |
| 3 | +$8.06M | |
| 4 |
WP
Woodline Partners
San Francisco,
California
|
+$6.89M |
| 5 |
Citigroup
New York
|
+$6.77M |
Top Sellers
| 1 | -$13.9M | |
| 2 | -$5.32M | |
| 3 | -$3.48M | |
| 4 |
Marshall Wace
London,
United Kingdom
|
-$1.88M |
| 5 |
PHP
Parkman Healthcare Partners
Stamford,
Connecticut
|
-$1.74M |